Summary BSD Medical Corporation (BSD) is a medical device company. The company designs, develops, manufactures and markets service systems for the treatment of cancer and other diseases using heat therapy using focused radio frequency and microwave energy. Its products include ablation systems including MicroThermX-180; and Hyperthermia Systems such as BSD-500, BSD-2000, BSD-2000/3D. BSD-500 is used to treat certain cancers located near the surface of the body. BSD’s BSD-2000 System is used to non-invasively treat certain deep cancers. The company’s MicroThermX MTX-180, has been developed to use precision-guided microwave energy to ablate soft tissue. It markets products in the US, Europe and Asia through a network of sales representatives and distributors. BSD is headquartered in Salt Lake City, Utah, the US. BSD Medical Corporation (BSDM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over... Research Beam Model: Research Beam Product ID: 127500 250 USD New
BSD Medical Corporation (BSDM) - Medical Equipment - Deals and Alliances Profile
 
 

BSD Medical Corporation (BSDM) - Medical Equipment - Deals and Alliances Profile

  • Category : Medical Devices
  • Published On : July   2014
  • Pages : 59
  • Publisher : GlobalData
 
 
 
Summary

BSD Medical Corporation (BSD) is a medical device company. The company designs, develops, manufactures and markets service systems for the treatment of cancer and other diseases using heat therapy using focused radio frequency and microwave energy. Its products include ablation systems including MicroThermX-180; and Hyperthermia Systems such as BSD-500, BSD-2000, BSD-2000/3D. BSD-500 is used to treat certain cancers located near the surface of the body. BSD’s BSD-2000 System is used to non-invasively treat certain deep cancers. The company’s MicroThermX MTX-180, has been developed to use precision-guided microwave energy to ablate soft tissue. It markets products in the US, Europe and Asia through a network of sales representatives and distributors. BSD is headquartered in Salt Lake City, Utah, the US.

BSD Medical Corporation (BSDM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
BSD Medical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 7
BSD Medical Corporation, Medical Equipment Deals By Type, 2008 to YTD 2014 8
BSD Medical Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 9
BSD Medical Corporation, Medical Equipment, Deals By Market, 2008 to YTD 2014 10
BSD Medical Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 11
BSD Medical Corporation, Medical Equipment, Deal Details 12
Partnerships 12
BSD Medical Enters Into Licensing Agreement With Linden Bioscence For Hyperthermia Products 12
BSD Medical Enters Into Distribution Agreement With Terumo Europe 13
Dalian Orientech Extends Distribution Agreement With BSD Medical For BSD-2000 Hyperthermia System 14
BSD Medical Enters Into Collaboration With GE Medical Systems 15
Equity Offering 16
BSD Medical to Raise USD5 Million in Private Placement of Shares and Warrants 16
BSD Medical Completes Private Placement Of Common Stock And Warrants For US$5 Million 17
BSD Medical Completes Registered Direct Offering For US$11 Million 18
BSD Medical Completed Registered Direct Offering Of US$2.75 Million 20
BSD Medical Completes Registered Direct Offering Of Common Stock For US$2.5 Million 22
BSD Medical Completes Registered Direct Offering Of Common Stock For US$2 Million 23
Asset Transactions 25
Dalian Orientech Acquires BSD-2000 Hyperthermia System From BSD Medical 25
Texas Oncology Acquires BSD-500 Hyperthermia System From BSD Medical 26
BSD Medical Corporation - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Financial Announcements 30
Jul 10, 2014: BSD Medical Announces Third Quarter Fiscal 2014 Financial Results 30
Apr 09, 2014: BSD Medical Announces Second Quarter Fiscal 2014 Financial Results 31
Mar 06, 2014: BSD Medical’s Fiscal Second Quarter Revenues Increase 106% to $1.7 Million 32
Jan 09, 2014: BSD Medical Announces First Quarter Fiscal 2014 Financial Results 32
Nov 07, 2013: BSD Medical Announces Fiscal Year 2013 Financial Results 33
Jul 10, 2013: BSD Medical Announces Third Quarter Fiscal 2013 Financial Results 34
Mar 28, 2013: BSD Medical Reports Q2 Fiscal 2013 Results 34
Jan 10, 2013: BSD Medical Reports Q1 Fiscal 2013 Results 35
Corporate Communications 36
Apr 29, 2014: BSD Medical Board of Directors Announces CEO Succession Plan 36
Apr 23, 2014: BSD Medical Receives Approval to Transfer Listing to NASDAQ Capital Market 36
Government and Public Interest 36
Nov 14, 2013: BSD Medical Corporation announces investor & analyst update conference call 36
Aug 21, 2013: BSD Medical to Present at The 15th Annual Rodman & Renshaw Global Investment Conference on September 9, 2013 37
Product News 37
Jul 10, 2014: BSD Medical Signs Distribution Agreement with Comed Medical Specialties for MicroThermX Microwave Ablation Products 37
Jul 07, 2014: BSD Medical Debuts University of Utah’s Huntsman Cancer Institute as U.S. Teaching Center for MicroThermX Microwave Ablation System 38
Jun 24, 2014: BSD Medical Reports Terumo Obtains Regulatory Approvals for Marketing MicroThermX Microwave Ablation System in Additional Countries 38
Jun 11, 2014: BSD Medical Reports Start Of Clinical Trial Using MicroThermX System To Treat Liver Tumours 39
Jun 05, 2014: BSD Medical Hyperthermia Systems Featured at the Society for Thermal Medicine Annual Conference 39
Jun 02, 2014: BSD Medical Announces Shipment of Third BSD-2000 Hyperthermia System to Taiwan Distributor 40
May 29, 2014: BSD Medical Announces Egyptian Ministry of Health Marketing and Import License Approval for the MicroThermX Microwave Ablation System in Egypt and Shipment of Products to Distributor 40
May 19, 2014: BSD Medical’s MicroThermX Microwave Ablation System Featured at European Conference on Interventional Oncology 41
Apr 22, 2014: BSD Medical Ships BSD-2000/3D/MR Image Guided Hyperthermia System for Installation at Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands 41
Apr 03, 2014: BSD Showcases MicroThermX Microwave Ablation System at SIR - the World’s Most Comprehensive Conference for Interventional Radiology Products 42
Mar 03, 2014: BSD Medical Reports on Continued Sales Momentum by Terumo for the MicroThermX Microwave System 42
Feb 25, 2014: BSD Medical Announces Taiwan Food and Drug Administration Marketing Approval for the BSD-2000 43
Feb 06, 2014: BSD Medical Announces Taiwan Food and Drug Administration Marketing and Import License Approval for the BSD-2000 is in Process 43
Feb 06, 2014: BSD Medical’s MicroThermX Featured in a Presentation at Clinical Interventional Oncology Conference 44
Jan 28, 2014: BSD Medical Announces Sale of the MicroThermX Microwave Ablation Products in Egypt 45
Dec 17, 2013: BSD Medical Announces Purchase of BSD-500 Hyperthermia System by Loyola University Medical Center 45
Dec 05, 2013: BSD Medical Announces Sale of the MicroThermX Microwave Ablation Systems in Turkey 46
Nov 21, 2013: BSD Medical’s System Featured at Symposium on Hyperthermia for the Treatment of Cancer in Turkey 46
Nov 19, 2013: BSD Medical Receives Order for a BSD-2000/3D/MR Image Guided Hyperthermia System for Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands 47
Oct 30, 2013: BSD Medical Announces First Symposium on Hyperthermia Treatment of Cancer in Taiwan to Feature BSD-2000 Hyperthermia System 47
Oct 24, 2013: BSD Reports Increasing European Market Penetration by Terumo for MicroThermX Microwave Ablation System 48
Oct 21, 2013: BSD Medical Sells BSD-2000 Hyperthermia System to Chinese Distributor 48
Oct 09, 2013: BSD Reports Successful Promotion of the MicroThermX Microwave Ablation System at CIRSE by Terumo Europe 48
Sep 04, 2013: Terumo to Showcase BSD's MicroThermX Microwave Ablation System at CIRSE – World's Largest Interventional Radiology Conference 49
Jul 17, 2013: BSD Medical Reports Seminal Study Published in The Lancet Oncology Demonstrates Impressive Long-Term Results from Hyperthermia Treatment of Children and Adolescents with Recurrent or Refractory Germ Cell Tumors 49
Jul 08, 2013: Terumo Begins Commercial Distribution of BSD's MicroThermX Microwave Ablation System at ECIO Following Successful Training of Sales Personnel 50
Jun 05, 2013: BSD Medical Delivers BSD-2000 Hyperthermia System To CTCA In Arizona 50
May 22, 2013: University Hospital In New Jersey Purchases BSD Medical’s MicroThermX Microwave Ablation System 51
May 13, 2013: BSD Medical Announces BSD-2000 Marketing Approval Submission To TFDA By Linden Bioscience 51
May 08, 2013: BSD Medical Gets Purchase Order For BSD-2000 Hyperthermia Systems In Taiwan 51
Feb 26, 2013: BSD Medical Reports Significant Growth Of MicroThermX Disposable SynchroWave Antennas 52
Feb 05, 2013: BSD Medical Reports Publication Of Clinical Study Results Of Hyperthermia Using BSD-2000 And Chemotherapy To Treat Advanced Pancreatic Cancer Patients 52
Jan 31, 2013: East Coast US Academic Medical Center Purchases BSD-500 Hyperthermia System From BSD Medical 53
Jan 28, 2013: BSD Medical Announces Sale Of MicroThermX Microwave Ablation System In Greece 53
Jan 17, 2013: BSD Medical Announces Dr James G Carlisle And MicroThermX Microwave Ablation System Profiled In Healthcare Heroes Article 53
Jan 14, 2013: BSD Medical Announces Sale Of MicroThermX Microwave Ablation Systems In Turkey 54
Jan 07, 2013: Horizon Medical Services Purchases BSD-500 Hyperthermia System From BSD Medical 54
Product Approvals 55
Jun 24, 2014: BSD Medical Reports Terumo Obtains Regulatory Approvals for Marketing MicroThermX Microwave Ablation System in Additional Countries 55
May 29, 2014: BSD Medical Announces Egyptian Ministry of Health Marketing and Import License Approval for the MicroThermX Microwave Ablation System in Egypt and Shipment of Products to Distributor 55
Feb 25, 2014: BSD Medical Announces Taiwan Food and Drug Administration Marketing Approval for the BSD-2000 55
Feb 06, 2014: BSD Medical Announces Taiwan Food and Drug Administration Marketing and Import License Approval for the BSD-2000 is in Process 56
Clinical Trials 57
Jun 11, 2014: BSD Medical Reports Start Of Clinical Trial Using MicroThermX System To Treat Liver Tumours 57
Other Significant Developments 57
Dec 11, 2013: BSD Medical Signs Distribution Agreement with and Ships MicroThermX Microwave Ablation Products to Active Medical 57
Aug 19, 2013: BSD Medical Corporation's President & CEO Interviewed by The Wall Street Transcript 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
List Of Tables
List of Tables
BSD Medical Corporation, Medical Equipment, Key Facts, 2013 1
BSD Medical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 1
BSD Medical Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 1
BSD Medical Corporation, Medical Equipment, Deals By Market, 2008 to YTD 2014 1
BSD Medical Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 1
BSD Medical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 7
BSD Medical Corporation, Medical Equipment Deals By Type, 2008 to YTD 2014 8
BSD Medical Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 9
BSD Medical Corporation, Deals By Market, 2008 to YTD 2014 10
BSD Medical Corporation, Medical Equipment, Deals Summary, 2008 to YTD 2014 11
BSD Medical Enters Into Licensing Agreement With Linden Bioscence For Hyperthermia Products 12
BSD Medical Enters Into Distribution Agreement With Terumo Europe 13
Dalian Orientech Extends Distribution Agreement With BSD Medical For BSD-2000 Hyperthermia System 14
BSD Medical Enters Into Collaboration With GE Medical Systems 15
BSD Medical to Raise USD5 Million in Private Placement of Shares and Warrants 16
BSD Medical Completes Private Placement Of Common Stock And Warrants For US$5 Million 17
BSD Medical Completes Registered Direct Offering For US$11 Million 18
BSD Medical Completed Registered Direct Offering Of US$2.75 Million 20
BSD Medical Completes Registered Direct Offering Of Common Stock For US$2.5 Million 22
BSD Medical Completes Registered Direct Offering Of Common Stock For US$2 Million 23
Dalian Orientech Acquires BSD-2000 Hyperthermia System From BSD Medical 25
Texas Oncology Acquires BSD-500 Hyperthermia System From BSD Medical 26
BSD Medical Corporation, Key Competitors 27
BSD Medical Corporation, Key Employees 28
List Of Figures
List of Figures
BSD Medical Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 1
BSD Medical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 7
BSD Medical Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 8
BSD Medical Corporation, Medical Equipment, Deals By Region, 2008 to YTD 2014 9
BSD Medical Corporation, Medical Equipment, Deals by Market, 2008 to YTD 2014 10
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter